網(wǎng)站首頁(yè)>產(chǎn)品展示 > 衍生化/食品/藥品等標(biāo)準(zhǔn)品 > OLchem植物生長(zhǎng)素 > olchemim Labelled plant growth regulators Cytokini

olchemim Labelled plant growth regulators Cytokini

發(fā)布時(shí)間：2024-06-13

訪問(wèn)次數(shù)：1723

公司地址：廣州市天河區(qū)天河北路僑林街47號(hào)中旅商務(wù)大廈東塔25E

產(chǎn)品價(jià)格：來(lái)電咨詢

產(chǎn)品詳情在線留言

The labelled natural cytokinins can be distinguished in the MS analysis because the m/z values of their mass spectral fragments are displaced by several mass units (m/z > 2 amu). A known quantity of the labelled cytokinin is added to the initial extract, and after purification the molar ratio of natural cytokinin to labelled internal standard is determined by mass spectrometry. The quantitative analysis by MS was first carried out by Thompson et al., Planta, 124: 207, 1975.

[¹⁵N₅]ADENINE (¹⁵N-Ade) [6-amino[¹⁵N₅]purine]

MW 139.10; crystalline; purity > 97% (HPLC)
R:22, S:22, 36; C₅H₅¹⁵N₅

	030 0241	1	mg
	030 0242	2	mg
	030 0243	5	mg

[²H₇]N⁶-BENZYLADENINE (D-BA) [6-[²H₇]benzylaminopurine]

MW 232.29; crystalline; purity > 97% (HPLC)
R:36/37/38, S:26, 36; CAS: 147028-87-3; C₁₂H₄²H₇N₅

	030 0221	1	mg
	030 0222	2	mg
	030 0223	5	mg

[²H₇]N⁶-BENZYLADENOSINE (D-BAR) [6-[²H₇]benzylamino-9-β-D-ribofuranosylpurine]

MW 364.41; crystalline; purity > 97% (HPLC)
S:26, 36; C₁₇H₁₂²H₇N₅O₄

	030 0551	1	mg
	030 0552	2	mg
	030 0553	5	mg

[²H₇]N⁶-BENZYLADENINE-9-GLUCOSIDE (D-BA9G) [6-[²H₇]benzylamino-9-β-D-glucopyranosylpurine]

MW 394.44; crystalline; purity > 97% (HPLC)
R: 36/37/38, S: 26, 36; C₁₈H₁₄²H₇N₅O₅

	030 3281	1	mg
	030 3282	2	mg
	030 3283	5	mg

[²H₇]N⁶ - BENZYLADENOSINE-5'-MONOPHOSPHATE SODIUM SALT (D-BAMP) [6-[²H₇]benzylamino-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

MW 506.38; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₇H₁₁²H₇N₅Na₂O₇P.H₂O

	030 5001	1	mg
	030 5002	2	mg
	030 5003	5	mg

[²H₃]DIHYDROZEATIN (D-DHZ) [6-[²H₃](4-hydroxy-3-methylbutylamino)purine]

MW 224.28; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 175733-30-9; C₁₀H₁₂²H₃N₅O

	030 0601	1	mg
	030 0602	2	mg
	030 0603	5	mg

[¹⁵N-N⁴]DIHYDROZEATIN (15N-DHZ) [6-[¹⁵N-N⁴](4-hydroxy-3-methylbutylamino)purine]

MW 225.24; crystalline; purity > 98% (HPLC)
S:26, 36; C₁₀H₁₂N¹⁵N₄O

	030 7021	1	mg
	030 7022	2	mg
	030 7023	5	mg

[²H₃]DIHYDROZEATIN RIBOSIDE (D-DHZR)[6-[²H₃](4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosylpurine]

MW 356.40; crystalline; purity > 97% (HPLC)
S:26, 36; CAS: 175733-31-0; C₁₅H₂₀²H₃N₅O₅

	030 0611	1	mg
	030 0612	2	mg
	030 0613	5	mg

[²H₃]DIHYDROZEATIN RIBOSIDE-5'-MONOPHOSPHATE (D-DHZMP) [6-[²H₃](4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosyl purine-5'-monophosphate disodium monohydrate]

MW 498.36; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₅H₁₉²H₃N₅Na₂O₈P.H₂O

	030 5011	1	mg
	030 5012	2	mg
	030 5013	5	mg

[²H₃]DIHYDROZEATIN-9-GLUCOSIDE (D-DHZ9G)[6-[²H₃](4-hydroxy-3-methylbutylamino)-9-β-D-glucopyranosylpurine]

MW 386.43; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₆H₂₂²H₃N₅O₆

	030 0631	1	mg
	030 0632	2	mg
	030 0633	5	mg

[²H₇]DIHYDROZEATIN-O-GLUCOSIDE (D-DHZOG) [6-[²H₇](4-hydroxy-3-methylbytylamino)-O-β-D-glucopyranosylpurine]

MW 390.45; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₆H₁₈²H₇N₅O₆

	030 0641	1	mg
	030 0642	2	mg
	030 0643	5	mg

[²H₇]DIHYDROZEATIN-O-GLUCOSIDE RIBOSIDE (D-DZROG) [6-[²H₇](4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosyl-O-β-D-glucopyranosylpurine]

MW 522.56; crystalline; purity > 95% (HPLC)
S:26, 36; C₂₁H₂₆²H₇N₅O₁₀

	030 0651	1	mg
	030 0652	2	mg
	030 0653	5	mg

[¹⁵N-N⁴]HYPOXANTINE (15N-Hyp) [6-[¹⁵N-N⁴]hydroxypurine]

MW 140.09; crystalline; purity > 97% (HPLC)
S:26, 36; C₅H₄¹⁵N₄O

	030 5941	1	mg
	030 5942	2	mg
	030 5943	5	mg

[²H₆]N⁶-ISOPENTENYLADENINE (D-iP) [6-[²H₆](3,3-dimethylallylamino)purine]

MW 209.29; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 175733-28-5; C₁₀H₇²H₆N₅

	030 0161	1	mg
	030 0162	2	mg
	030 0163	5	mg

[¹⁵N₄-N⁶]-ISOPENTENYLADENINE (15N4-iP) [6-[¹⁵N₄](3,3-dimethylallylamino)purine]

MW 207.22; crystalline; purity > 98% (HPLC)
S:26, 36; C₁₀H₁₃¹⁵N₄N

	030 7371	1	mg
	030 7372	2	mg
	030 7373	5	mg

[²H₆]N⁶-ISOPENTENYLADENOSINE (D-iPR) [6-[²H₆](3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]

MW 341.41; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 175733-29-6; C₁₅H₁₅²H₆N₅O₄

	030 0171	1	mg
	030 0172	2	mg
	030 0173	5	mg

[¹⁵N]N⁶-ISOPENTENYLADENOSINE (15N-iPR) [6-[¹⁵N](3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]

MW 336.36; crystalline; purity > 98% (HPLC)
S:26, 36; C₁₅H₂₁N₄¹⁵NO₄

	030 7031	1	mg
	030 7032	2	mg
	030 7033	5	mg

[²H₆]N⁶-ISOPENTENYLADENOSINE-5'-MONOPHOSPHATE (D-iPMP) [6[²H₆]-(3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

MW 483.37; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₅H₁₄²H₆N₅Na₂O₇P.H₂O

	030 5041	1	mg
	030 5042	2	mg
	030 5043	5	mg

[²H₆]N⁶-ISOPENTENYLADENINE-7-GLUCOSIDE(D-iP7G)[6-[²H₆] (3,3-dimethylallylamino)-7-β-D-glucopyranosylpurine]

MW 371.43; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₆H₁₇²H₆N₅O₅

	030 5051	1	mg
	030 5052	2	mg
	030 5053	5	mg

[²H6] N⁶-ISOPENTENYLADENINE-9-GLUCOSIDE (D-iP9G) [6-[²H₆] (3,3-dimethylallylamino)-9-β-D-glucopyranosylpurine]

MW 371.43; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₆H₁₇²H₆N₅O₅

	030 0231	1	mg
	030 0232	2	mg
	030 0233	5	mg

[²H₆]2-METHYLTHIO-N⁶-ISOPENTENYLADENINE (D-2MeSiP) [2-methylthio-6-[²H₆](3,3-dimethylallylamin)purine]

MW 255.38; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₀H₇²H₆N₅S

	030 5071	1	mg
	030 5072	2	mg
	030 5073	5	mg

[²H₆]2-METHYLTHIO-N⁶-ISOPENTENYLADENOSINE (D-2MeSiPR) [2-methylthio-6-[²H₆](3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]

MW 387.50; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₆H₁₇²H₆N₅O₄S

	030 5061	1	mg
	030 5062	2	mg
	030 5063	5	mg

[¹⁵N₄]KINETIN(15N-K) [6-furfurylamino[¹⁵N₄]purine]

MW 219.19; CRYSTALLINE; purity > 97% (HPLC)
S:26, 36; C₁₀H₉N¹⁵N₄O

	030 0341	1	mg
	030 0342	2	mg
	030 0343	5	mg

[¹⁵N-N⁴]meta-METHOXYTOPOLIN (15N-MemT) [6-(3-methoxybenzylamino)[¹⁵N₄]purine]

MW 259.25; crystalline; purity > 98% (HPLC)
S:26, 36; C₁₃H₁₃N¹⁵N₄O

	030 0511	1	mg
	030 0512	2	mg
	030 0513	5	mg

[¹⁵N₄]meta-TOPOLIN (15N-mT) [6-(3-hydroxybenzylamino)[¹⁵N₄]purine]

MW 245.23; CRYSTALLINE; purity >97% (HPLC)
S:26, 36; C₁₂H₁₁N¹⁵N₄O

	030 0101	1	mg
	030 0102	2	mg
	030 0103	5	mg

[¹⁵N₄]ortho-TOPOLIN (15N-oT) [6-(2-hydroxybenzylamino)[¹⁵N₄]purine]

MW 245.23; CRYSTALLINE; purity >98% (HPLC)
S:26, 36; C₁₂H₁₁N¹⁵N₄O

	030 0121	1	mg
	030 0122	2	mg
	030 0123	5	mg

[¹⁵N₄]para-TOPOLIN (15N-pT) [6-(4-hydroxybenzylamino)[¹⁵N₄]purine]

MW 245.23; CRYSTALLINE; purity >98% (HPLC)
S:26, 36; C₁₂H₁₁N¹⁵N₄O

	030 0451	1	mg
	030 0452	2	mg
	030 0453	5	mg

[²H₅]trans-ZEATIN (D-tZ)[6-[²H₅]((E)-4-hydroxy-3-methylbut-2-enylamino)purine]

MW 224.28; crystalline; purity > 98% (HPLC); cis isomer <5%
S:26, 36; CAS: 72963-19-0; C₁₀H₈²H₅N₅O

	030 0301	1	mg
	030 0302	2	mg
	030 0303	5	mg

[¹⁵N]trans-ZEATIN (15N-tZ) [6-((E)-4-hydroxy-3-methylbut-2-enylamino) purine]

MW 220.24; crystalline; purity > 98% (HPLC)
S:26, 36; C₁₀H₁₃N₄¹⁵NO

	030 7041	1	mg
	030 7042	2	mg
	030 7043	5	mg

[¹⁵N₄]trans-ZEATIN (15N4-tZ) [6-[¹⁵N₄]((E)-4-hydroxy-3-methylbut-2-enylamino) purine]

MW 223.22; crystalline; purity > 98% (HPLC)
S:26, 36; C₁₀H₁₃¹⁵N₄NO

	030 7381	1	mg
	030 7382	2	mg
	030 7383	5	mg

[²H₅]trans-ZEATIN RIBOSIDE (D-tZR) [6-[²H₅]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]

MW 356.40; crystalline; purity > 97% (HPLC); cis isomer <0.2%
S:26, 36; CAS: 72963-21-4; C₁₅H₁₆²H₅N₅O₅

	030 0311	1	mg
	030 0312	2	mg
	030 0313	5	mg

[²H₅]trans-ZEATIN-7-GLUCOSIDE (D-tZ7G) [6-[²H₅]((E)-4-hydroxy-3-methylbut-2-enylamino)-7-β-D-glucopyranosylpurine]

MW 386.42; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₆H₁₈²H₅N₅O₆

	030 5111	1	mg
	030 5112	2	mg
	030 5113	5	mg

[²H₅]trans-ZEATIN-9-GLUCOSIDE (D-tZ9G) [6-[²H₅]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-glucopyranosylpurine]

MW 386.42; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 84744-92-3; C₁₆H₁₈²H₅N₅O₆

	030 0471	1	mg
	030 0472	2	mg
	030 0473	5	mg

[²H₅]trans-ZEATIN-O-GLUCOSIDE (D-tZOG) [6-[²H₅]((E)-4-hydroxy-3-methylbut-2-enylamino)-O-β-D-glucopyranosylpurine]

MW 386.42; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 72963-23-6; C₁₆H₁₈²H₅N₅O₆

	030 5121	1	mg
	030 5122	2	mg
	030 5123	5	mg

[²H₅]trans-ZEATIN-O-GLUCOSIDE RIBOSIDE (D-tZROG) [6-[²H₅]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosyl-O-β-D-glucopyranosylpurine]

MW 518.54; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 69700-29-4; C₂₁H₂₆²H₅N₅O₁₀

	030 5131	1	mg
	030 5132	2	mg
	030 5133	5	mg

[²H₅]trans-ZEATIN RIBOSIDE-5'-MONOPHOSPHATE (D-tZMP) [6-[²H₅]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

MW 498.29; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₅H₁₅²H₅N₅Na₂O₈P.H₂O

	030 5141	1	mg
	030 5142	2	mg
	030 5143	5	mg

[²H₅]2-METHYLTHIO-trans-ZEATIN (D-2MetSZ) [2-methylthio-6-[²H₅]((E)-4-hydroxy-3-methylbut-2-enylamino)purine]

MW 270.37; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₁H₁₀²H₅N₅OS

	030 5171	1	mg
	030 5172	2	mg
	030 5173	5	mg

[²H₅]2-METHYLTHIO-trans-ZEATIN RIBOSIDE (D-2MeStZR) [2-methylthio-6-[²H₅]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]

MW 402.49; crystalline; purity > 95% (HPLC)
S:26, 36; C₁₆H₁₈²H₅N₅O₅S

	030 5181	1	mg
	030 5182	2	mg
	030 5183	5	mg

[¹⁵N₄]cis-ZEATIN (15N-cZ) [6-[¹⁵N₄]((Z)-4-hydroxy-3-methylbut-2-enylamino) purine]

MW 223.22; crystalline; purity > 98% (HPLC)
S:26, 36; C₁₀H₁₃N¹⁵N₄O

	030 0321	1	mg
	030 0322	2	mg
	030 0323	5	mg

上一條：olchemim Phytohormone standards Strigolactones

下一條：olchemim Labelled plant growth regulators Auxins

olchemim Labelled plant growth regulators Cytokini

留言框

產(chǎn)品：

您的單位：

您的姓名：

聯(lián)系電話：

常用郵箱：

省份：

詳細(xì)地址：

補(bǔ)充說(shuō)明：

驗(yàn)證碼：